Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
about
Control of avian coccidiosis: future and present natural alternativesToxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosisToxoplasma gondii immune mapped protein 1 is anchored to the inner leaflet of the plasma membrane and adopts a novel protein fold.Identification and characterization of Eimeria tenella apical membrane antigen-1 (AMA1)Identification and characterization of a serpin from Eimeria acervulina.Recombinant TgHSP70 Immunization Protects against Toxoplasma gondii Brain Cyst Formation by Enhancing Inducible Nitric Oxide Expression.Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse ModelTranscriptome analysis in chicken cecal epithelia upon infection by Eimeria tenella in vivo.Parasite distribution and associated immune response during the acute phase of Toxoplasma gondii infection in sheepPrime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in MiceA comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models.Identification of immune protective genes of Eimeria maxima through cDNA expression library screening.Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in miceVaccines against Toxoplasma gondii: status, challenges and future directions.Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.Dietary supplementation of mannan-oligosaccharide enhances neonatal immune responses in chickens during natural exposure to Eimeria sppExperimental infection with a low virulence isolate of Neospora caninum at 70 days gestation in cattle did not result in foetopathyIn vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.Veterinary vaccines against Toxoplasma gondii.Vaccines against Toxoplasma gondii: challenges and opportunities.Current status of toxoplasmosis vaccine development.Immuno-Efficacy of a T. gondii Secreted Protein with an Altered Thrombospondin Repeat (TgSPATR) As a Novel DNA Vaccine Candidate against Acute Toxoplasmosis in BALB/c Mice.Ovine toxoplasmosis.Vaccines against Toxoplasma gondii: new developments and perspectives.Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken.Recent advances in developing vaccines against Toxoplasma gondii: an update.Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondiiMast cell activator compound 48/40 is not an effective adjuvant for UV-attenuated Toxoplasma gondii vaccine.Infection of primary canine duodenal epithelial cell cultures with Neospora caninum.Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16.A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles.Identification and partial characterization of a serine protease inhibitor (serpin) of Eimeria tenella.Immunogenicity of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine strains carrying a gene that encodes Eimeria tenella antigen SO7.Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.Immunological interaction between Giardia cyst extract and experimental toxoplasmosis.NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum.In vitro effects of aqueous extracts of Astragalus membranaceus and Scutellaria baicalensis GEORGI on Toxoplasma gondii.
P2860
Q27010445-17188E4C-FA16-4613-A3E2-DA67E4A082B4Q28757592-B2E0876E-B5F3-4C94-A4CE-097042B60A28Q30395669-8FA424F6-9B83-4A63-9549-13A92853D511Q31075939-3FD37EB7-CC88-4A19-BFDC-4294C7EBFF40Q33346405-A626D301-4E2E-4A99-B1B0-8E89548DC1C0Q33599823-34961A99-EBE5-4E49-B597-D4079CE3B987Q34494113-C44E558D-42E8-487E-96E4-9D9AAFD23CFDQ34533592-B57F5494-0A49-410E-9986-5AA907822582Q34758681-CE2528D8-49B8-4966-B111-904B478C818EQ34788148-8B8C7BC2-945F-40CD-A2A0-C37404EB8A69Q35641195-7F8FF36B-6F75-4A8B-AB3D-39560A93B805Q35843444-FC8ACEFB-785F-49A4-A6DB-C6CDD09EBB30Q36010732-0670BC64-72CF-4F3E-BA9D-FBF72F623AD9Q36283463-3924AD28-9C3C-4002-8631-28C434452D76Q36505163-0654B00B-A0B7-42DC-B480-23BC36E01BB0Q36631309-6BB55F2E-E2AB-4CD0-9AD7-8309217D7EEAQ36955470-47571339-C5FA-42EA-81B1-AB182744F334Q37154858-7DE13B11-C55B-454F-80A5-E0A1AF5D54DDQ37246826-9C20AC2F-632D-4598-9910-2A381B67FD70Q37263372-4A7D9199-1570-450E-AC55-20E0456E08EFQ37476756-45A29120-189A-44E3-B66D-58FECAEC5039Q37476759-DEBB8FD9-B932-4C35-8F73-7289814E83AAQ37503262-D94DCB94-E432-4A04-8E94-99C3EEFFEED2Q37647762-F7B82421-8769-4891-98B5-00B45E2D0D3BQ37648799-1246E25A-3271-4174-A3E1-F6CB0D814C68Q38149266-1238C5EA-E34D-40D9-B0A0-B3170470C27CQ38214121-714009E4-5690-43AA-B043-341DB7651715Q38607376-B4F3B253-8271-48D3-B8D3-A0EC17D68D3BQ38898115-93F933B4-DD90-4670-AF3B-C94516DD19BEQ39177126-2221F02E-26D4-4692-AA2A-A8DDA646D9F8Q40041991-2881E411-F554-44C1-82AA-BC7EFF5617D9Q40065419-153E7BB6-3EE4-4D81-83B2-11F8E3F53A94Q41071634-8C4BF5F7-B39E-4B63-B77B-EE2D365B67E7Q42613012-E658D0F6-4BA9-4ECE-B1D1-C6FB4F2120D0Q43242652-4EE870F2-40C1-4DC2-869F-9A0FC50A50FBQ43501975-05CD4179-BF72-4416-8EDF-36C392A4CB3EQ43704579-F27A4EC2-3D2F-4417-9F06-D43FAA1D06ADQ46208643-2C4C2344-C5B1-467C-AD80-0F0FD5DF1F2EQ46543747-13A030FE-4011-4E23-9F65-693BD1C8B5B4Q50505908-F8CB8CA9-31CA-4F84-91EB-234B4AB459A9
P2860
Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vaccination as a control strat ...... eria, Toxoplasma and Neospora.
@ast
Vaccination as a control strat ...... eria, Toxoplasma and Neospora.
@en
type
label
Vaccination as a control strat ...... eria, Toxoplasma and Neospora.
@ast
Vaccination as a control strat ...... eria, Toxoplasma and Neospora.
@en
prefLabel
Vaccination as a control strat ...... eria, Toxoplasma and Neospora.
@ast
Vaccination as a control strat ...... eria, Toxoplasma and Neospora.
@en
P2860
P1433
P1476
Vaccination as a control strat ...... eria, Toxoplasma and Neospora.
@en
P2093
Vermeulen AN
P2860
P304
P356
10.1017/S0031182006001855
P478
P577
2006-01-01T00:00:00Z